Literature DB >> 11198762

Depression: a role for neurosurgery?

G S Malhi1, J R Bartlett.   

Abstract

After providing an overview of depression this article briefly reviews the development of psychosurgery and outlines the current procedures in use world wide. Stereotactic subcaudate tractotomy (SST) is described in particular detail, and the rationale for its use in the treatment of resistant depression is then discussed by considering the findings of neuropsychological, neurophysiological and neuroimaging studies. The emerging evidence suggests that the prefrontal cortex subserves an essential function in emotion and that disruption of its connections modifies mood.

Entities:  

Mesh:

Year:  2000        PMID: 11198762     DOI: 10.1080/02688690050175193

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  5 in total

1.  Neurosurgical interventions for neuropsychiatric syndromes.

Authors:  C Alan Anderson; David B Arciniegas
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

Review 2.  Psychosurgery and deep brain stimulation as ultima ratio treatment for refractory depression.

Authors:  Georg Juckel; Idun Uhl; Frank Padberg; Martin Brüne; Christine Winter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-01-09       Impact factor: 5.270

Review 3.  The neural bases of obsessive-compulsive disorder in children and adults.

Authors:  Tiago V Maia; Rebecca E Cooney; Bradley S Peterson
Journal:  Dev Psychopathol       Date:  2008

4.  Authenticity, depression, and deep brain stimulation.

Authors:  Veronica Johansson; Martin Garwicz; Martin Kanje; Jens Schouenborg; Anders Tingström; Ulf Görman
Journal:  Front Integr Neurosci       Date:  2011-05-23

5.  "Getting physical": the management of neuropsychiatric disorders using novel physical treatments.

Authors:  Gin S Malhi; Colleen Loo; Catherine M Cahill; Jim Lagopoulos; Philip Mitchell; Perminder Sachdev
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.